BHUTAN
Total # cancer cases (2018)
Total # cancer deaths (2018)
585 490
16.3%
aPAF, cancer deaths bPAF, cancer cases cPAF, melanoma cases
TRENDS
Estimated past and future trends in total cases per year (breast and lung) Probability of premature death from cancer per year
INVESTMENT CASE (2019)
*Lower middle income
At this income level, investing in a package of essential services and scaling-up coverage will:
Costs per year Projected lives saved per year
BURDEN OF CANCER
16.2%
Total population (2019)
Tobacco (2017)a Alcohol (2016)a Infections (2012)b Obesity (2012)b
29.8% 0.8%
763,094
Premature deaths from NCDs (2016)
Cancer as % of NCD premature deaths (2016)
2.3%
PAFs
(population attributable fractions)
1,744
Cancer Country Profile 2020
UV (2012)c Occupational risk (2017)a
n/a 1.2%
8.2%
5.1%
3.4%
3.6%
6.0%
8.2%
7.5%
3.2%
3.1%
20.7%
6.5%
4.9%
3.7%
3.5%
6.7%
9.0%
8.6%
2.9%
3.7%
23.9%
Cervix uteri Colorectum Leukaemia Lip, oral cavity Liver Lung Oesophagus Ovary Pancreas Stomach
Most common cancer cases (2018)
Incidence Mortality
0 10 20 30 40 50 60 70
2020 2022 2024 2026 2028 2030
6.34%
6.15%6.00%5.94%5.87%5.88%5.80%5.77%5.73%5.75%5.77%5.79%5.83%5.87%
5.91%
5.87%5.86%5.84%5.83%5.81%5.79%5.78%5.76%5.75%5.73%5.71%5.70%
5.68%
5.52%5.38%5.25%5.12%4.99%4.86%4.73%4.60%4.46%4.33%4.20%4.07%
3.94%
2.00%
7.00%
12.00%
17.00%
2000 2005 2010 2015 2020 2025 2030
Past trends Projected linear trend SDG target 13
38
16
48 32
107
- 20 40 60 80 100 120
Breast cancer Lung cancer
2012 2018 2040
- 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50
2020 2022 2024 2026 2028 2030
US$ (per capita)
BHUTAN
HEALTH SYSTEM CAPACITY
aper 10,000 cancer patients
WORKFORCE
aper 10,000 cancer patients
Quality of mortality registration*** 2007-2016 No coverage 2019 no
# of radiation oncologista 2019 n/a
2019 0.0
# of mammographsa 2020 17.1 # of surgeonsa 2014 102.6
# of CT scannersa 2020 34.2 # of radiologista 2019 51.3
# of MRI scannersa 2020 17.1 # of nuclear medicine physiciana 2019 0.0
# of PET or PET/CT scannersa 2020 0.0 # of medical & pathology lab scientistsa 2017 1076.9
Integrated NCD plan 2019 operational 2019 17.1
NCCP (including cancer types) 2019 under development 2019 2 cancer(s)
MPOWER measures fully implemented and
achieved 2018
0
Pathology services 2019 generally availableCancer management guidelines 2019 yes 2019 generally not
available Palliative care included in their operational,
integrated NCD plan 2019 yes
2015-2017 15
Breast cancer screening program 2019 yes
*Defined daily doses for statistical purposes (S-DDD) per miliion inhabitants per day Breast cancer screening program: Starting
age, target population 2019
15
GLOBAL INITIATIVES
Elimination of Cervical Cancer Global Initiative for Childhood Cancer
HPV vaccination programme coverage 2018 89.6 2020 22
Cervical cancer screening 2019 yes Early detection programme/guidelines 2019 don't know
Screening programme type 2019 opportunistic Defined referral system 2019 don't know
Screening programme method 2019 PAP smear
Screening participation rates 2019
Early detection programme/guidelines 2019 yes
Defined referral system 2019 yes
***The mortality estimates for this country have a high degree of uncertainty because they are not based on any national NCD mortality data
>50% and <70%
Annual cancer cases (0-14 years old) Bone marrow transplantation capacity
# Public cancer centres per 10,000 cancer patients
# of treatment services (surgery,
radiotherapy, chemotherapy) 2019 3 Availability of opioids* for pain
management Availability of population-based cancer
registry (PBCR)** 2019
# of external beam radiotherapy (photon,electron)a
Cancer Country Profile 2020
PBCR
2019 17.1
FORMULATING RESPONSE
Annual cancer cases (0-14 years old) Palliative care availability:
community/home-based care 2019 generally available Available staff in Ministry of Health who
dedicates significant proportion of their time to cancer
# of medical physicista
Early detection programme/ guidelines for 4 cancers (breast, cervix, colon, childhood)
6
1 0
1 1 1 12
Acute lymphoid leukaemia Hodgkin lymphoma Burkitt lymphoma CNS, low grade tumours Retinoblastoma Wilms tumour Other childhood cancer
